WATERS CORP /DE/ (WAT) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$436.55

From 52W high−2.22%

Volume468699.00

Market cap$42.67B

P/E (TTM)108.0x

P/S (TTM)9.2x

Div yield—

Key dataOct 19, 2026

Open

$436.55

From 52W high

−2.22%

Volume

468699.00

Market cap

$42.67B

ValuationView details →

P/E (Fwd)

27.2x

EV/EBITDA

49.8x

P/E (TTM)

108.0x

RSI (14)

54.3

MomentumView details →

1D Return

−0.61%

YTD Return

+14.50%

SummaryUpdated Jul 1, 2026

Waters Corporation (NYSE:WAT) is a specialty measurement company founded in 1958 and headquartered in Milford, Massachusetts. The company went public in 1995 and has established itself as a leading provider of analytical workflow solutions serving laboratory applications across pharmaceutical, industrial, academic, and governmental sectors worldwide. Waters operates through two primary segments: Waters (analytical instruments) and TA (thermal analysis), delivering high-performance liquid chromatography, mass spectrometry, and thermal analysis systems to customers in Asia, the Americas, and Europe.

Ask drillr about WATERS CORP /DE/ →

ValuationView details →

P/E (Fwd)

27.2x

P/E (TTM)

108.0x

EV/EBITDA

49.8x

EV/Sales

10.2x

P/S (TTM)

9.2x

P/B (TTM)

2.8x

ProfitabilityView details →

Gross Margin

50.78%

Net Margin

3.58%

EBITDA Margin

20.47%

ROE (TTM)

1.09%

ROA (TTM)

0.67%

Asset Turnover

0.19x

GrowthView details →

Revenue YoY

+52.47%

EPS YoY

−63.88%

FCF YoY

−35.67%

Revenue CAGR 3Y

+2.12%

EPS CAGR 3Y

−2.91%

EBITDA YoY

−10.08%

MomentumView details →

1D Return

−0.61%

YTD Return

+14.50%

1Y Return

+26.72%

RSI (14)

54.3

vs 50D SMA

+3.28%

vs 200D SMA

+18.66%

Capital & dividendView details →

Debt/Equity

0.35x

Current Ratio

1.86x

Quick Ratio

1.29x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$3.05

EPS Surprise

1.33%

Beats (12Q)

12/12

Next Q EPS Est

$4.68

Avg Surprise (4Q)

7.32%

Rev Surprise

1.40%

Financials snapshotView financials →

Revenue (TTM)

4.64B

Net Income (TTM)

166.14M

Op. CF (TTM)

549.86M

Next earningsNov 3, 2026 →

Latest newsMore news →

Waters commercially launched the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometry instrument featuring BD SpectralFX and FACSTruQ technologies.35d ago

Robert L. Carpio III resigned as Senior Vice President of Waters Analytical Sciences Division, effective August 20, 2026.60d ago

Similar companies

IQVIA Holdings Inc.IQV IDEXX Laboratories, Inc.IDXX Illumina, Inc.ILMN Agilent Technologies, Inc.A 昭衍新药603127.SH Hangzhou Tigermed Consulting Co., Ltd.03347.HK Find similar companies →

Latest newsMore news →

Waters commercially launched the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometry instrument featuring BD SpectralFX and FACSTruQ technologies.35d ago Robert L. Carpio III resigned as Senior Vice President of Waters Analytical Sciences Division, effective August 20, 2026.60d ago